glp-1 drugs adverse effects GI of Glucagon-Like Peptide-1 Receptor Agonists GLP-1 medication side effects for
Description
(Lausanne) 11, 1410668
Neuroscience Letters
and Matrisian L
Case 4: After a sleeve gastrectomy, a female patient with type 2 diabetes mellitus discontinued tirzepatide 7.5 mg as advised but resumed it independently due to rising fasting blood glucose levels
Endogenous incretin levels and risk of first incident cancer: a prospective cohort study
The meta-analyses reviewed highlight the favorable safety profile of the pharmacological therapy, alongside its efficacy in optimizing clinical parameters, particularly glycemic control and lipid profiles ( Table 3 )
